← Eichor
Study identifier: NCT06521710 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy

Condition: Prostate Cancer · Erectile Dysfunction  ·  Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

PhaseNA
Planned participants10
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The investigator proposing a single arm prospective pilot trial evaluating the safety and the 1-year erectile recovery outcomes of patients undergoing Nerve Restoring (NR) Robotically assisted laparoscopic radical prostatectomy (RALP). During this study a total of 10 patients who are undergoing robotic prostatectomy will have their surgery performed utilizing a novel technique, NR-RALP, which incorporates a genitofemoral (GFN) nerve graft designed to try to improve the erectile function and recovery of men undergoing standard of care robotic prostatectomy while minimizing additional morbidity of the procedure

This description comes directly from the study's public registry record.

Talk to the study team

Victor McPherson, MD  ·  514-340-8222  ·  victor.mcpherson@mcgill.ca

Oleg Loutochin  ·  514-340-8222  ·  oloutochin@jgh.mcgill.ca

Always discuss trial participation with your own doctor first.

Locations (2)

Jewish General Hospital, CIUSSS Centre-Ouest de l'île de MontréalMontreal, Quebec, CanadaRecruiting
Jewish General HospitalMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06521710